Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models-Reference-Cited by-同舟云学术

Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models

Published:2017 Issue:3 Volume:9 Page:309-322
ISSN:1756-5901
Container-title:Metallomics
language:en
Short-container-title:Metallomics

Author:

Göschl Simone,Schreiber-Brynzak Ekaterina,Pichler Verena,Cseh Klaudia,Heffeter Petra,Jungwirth Ute,Jakupec Michael A.^ORCID,Berger Walter,Keppler Bernhard K.

Funder

Austrian Science Fund

Publisher

Oxford University Press (OUP)

Subject

Metals and Alloys,Biochemistry,Biomaterials,Biophysics,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2017/MT/C6MT00226A

Reference46 articles.

1. Increased understanding of platinum anticancer chemistry

2. The status of platinum anticancer drugs in the clinic and in clinical trials

3. The resurgence of platinum-based cancer chemotherapy

4. Direct Cellular Responses to Platinum-Induced DNA Damage

5. Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Dimensional and Spheroid-Based Three-Dimensional Cell Culture Systems: Implications for Drug Discovery in Cancer;Drugs and Drug Candidates;2024-06-13

2. Light‐Responsive Nanoantennas Integrated into Nanoscale Metal–Organic Frameworks for Photothermal Drug Delivery;Small Science;2024-05-10

3. Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer therapy;Chinese Chemical Letters;2024-04

4. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies;Biomedicine & Pharmacotherapy;2024-02

5. New copper(ii) and oxidovanadium(iv) complexes with a vitamin B₆ Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models;Dalton Transactions;2024